For many families affected by the opioid crisis, OxyContin maker Purdue Pharma's bankruptcy has been a long and difficult process.
The proposal would mark a departure from the fates of other companies accused of stoking public-health crises.
A 5-4 split among Supreme Court justices just killed Purdue Pharma's bankruptcy plan — and the Sackler family's immunity from lawsuits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback